June 3, 2024  -  InvestmentNews

Femtech Investment Round-up (May 2024)

Investment

Reproductive health services company Rhea adds $10M in funding.

Male reproductive health startup Posterity Health raises $6M to fund expansion and technology acceleration.

Natural Cycles secures $55M in Series C funding to accelerator growth ahead of a possible IPO.

Gameto secures $33M in Series B funding to advance novel IVF tretments.

Hornet Therapeutics emerges from stealth with novel data on EBV treatment and funding from 4BIO capital.

Amino Health secures $10M to anhance AI-powered women's and LGPTQ+ healthcare navigation.

AmplexD Therapeutics secures $2M to advance HPV-induced cervical precancer treatments.

Acclinate secures $7M in Series A funding to drive health equity advancement.

May Health raises $25M in Series B funding to advance ovarian rebalancing therapy for PCOS.

Backpack Healthcare secures $14M in Series A funding to advnace pediatric mental health care.

Dandi secures $1.3M funding to enhance fertility care experience.

Testmate Health secures $6M in seed funding for game-changing at-home rapid STI test.

Germany-based Ovom Care raises €4.8M in seed fundin gor its AI-enabled hybrid fertility care model.

Acquisition

Lunit acquires Volpara to anhance AI-driven breast cancer screening and diagnostics.

Samsung acquires French fetal ultrasound AI software company Sonio.

Nameless CPG acquires menopause-focues supplement brand Wile.

Hologic to acquire Endomag, a breast surgical guidance company.